Sirius is a clinical stage biotech company developing innovative siRNA therapies for global markets. We are dedicated to discovering and developing new treatment options for cardiovascular and cerebrovascular disease and translating siRNA technology into transformative medicine for the treatment of chronic diseases. Our most advanced products are SRSD107 for the treatment of thromboembolic disorders, SRSD216 for the treatment of hyperlipoproteinemia, and SRSD101 for the treatment of dyslipidemia.
Founded in 2021 by a world-class leadership team and investors, Sirius has established an innovation center in San Diego, California in the United States and a translational medicine center in Shanghai, China. Sirius has raised nearly US$150 million funding to date from OrbiMed, Creacion Ventures, Hankang Capital, Delos Capital, and BioTrack Capital.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 11760 Sorrento Valley Road, Suite K,l
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.siriusrna.com/
- Keywords
- siRNA.
- HQ
- San Diego, California
Sirius Therapeutics, Inc. Questions
Sirius Therapeutics, Inc.'s website is https://www.siriusrna.com/
Sirius Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/sirius-therapeutics-inc
Sirius Therapeutics, Inc. has
5 employees.
View email and phone details for 5
employees at Sirius Therapeutics, Inc..
Sirius Therapeutics, Inc.'s industry is
Biotechnology Research
Sirius Therapeutics, Inc.'s top competitors are
Mirador Therapeutics,
Callio Therapeutics,
Attovia Therapeutics,
Taysha Gene Therapies,
Artiva Biotherapeutics,
Adarx Pharmaceuticals Inc.,
Solid Biosciences,
Glyphic Biotechnologies,
Airna,
Triastek, Inc..
Sirius Therapeutics, Inc.'s categories are Biotechnology Research
Sirius Therapeutics, Inc.'s founding year is 2021
